Loteprednol Etabonate 0.38% Ophthalmic Gel/Jelly

DRUG2 trials

Sponsors

Illinois College of Optometry, Retina Research Institute, LLC

Conditions

AllergyDiabetic RetinopathyDry EyeKeratoconusMacular Degeneration Choroidal NeovascularizationMacular EdemaVein Occlusion

Early Phase 1

Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus

CompletedNCT04418999

Illinois College of OptometryAllergy, Dry Eye, Keratoconus

Start: 2020-09-01End: 2021-12-31Updated: 2026-06-24

Phase 4

Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period

CompletedNCT07090044

Retina Research Institute, LLCDiabetic Retinopathy, Macular Degeneration Choroidal Neovascularization, Macular Edema +1

Start: 2021-08-20End: 2022-12-08Updated: 2025-07-29